|
Canada-0-TileNonCeramicDistributors Κατάλογοι Εταιρεία
|
Εταιρικά Νέα :
- Therapeutic approaches using nitric oxide in infants and children
This review will discuss the physiology of nitric oxide signaling, the most common indications for its clinical use, and promising new investigations that may enhance endogenous production of nitric oxide and or improve vascular response to it
- Use of Inhaled Nitric Oxide in Preterm Infants
The purpose of this clinical report is to summarize the existing evidence for the use of inhaled nitric oxide in preterm infants and provide guidance regarding its use in this population
- Inhaled nitric oxide use in newborns - Oxford Academic
Use of iNO is recommended in late preterm and term infants who develop HRF despite optimal oxygenation and ventilation strategies
- Nitric Oxide Therapy: Uses, How It’s Done, Benefits, and Risks
In this article, we look closely at nitric oxide therapy, why a newborn might need it, how the treatment is given, its benefits, possible risks, and when nitric oxide therapy should be
- Inhaled Nitric Oxide in Preterm Infants - Bubble CPAP Institute
Nitric oxide is a compound produced by many cells of the body It relaxes vascular smooth muscle by binding to the heme moiety of cytosolic guanylate cyclase, activating guanylate cyclase and increasing intracellular levels of cGMP, which then leads to vasodilatation
- Nitric oxide therapy in the neonate: guideline for the use of inhaled . . .
This guideline is applicable to all medical, nursing and midwifery staff involved in administering nitric oxide within the neonatal population in the West of Scotland
- Nitric oxide (inhalation route) - Side effects uses - Mayo Clinic
Nitric oxide is used together with a breathing machine (ventilator) and other agents to treat newborn (term and near-term) babies with respiratory failure that is caused by pulmonary hypertension Nitric oxide is a gas that is inhaled through the nose or mouth It works by relaxing the smooth muscles to widen the blood vessels in the lungs
- Inhaled nitric oxide in preterm infants with respiratory disease: a . . .
Inhaled nitric oxide (iNO) has been shown to be effective in term and near-term infants with specific respiratory diseases The effects and potential risks of iNO differ substantially in preterm infants with special pathophysiology
- Inhaled Nitric Oxide (iNO) - UCSF Benioff Childrens Hospital
Infants with PPHN have decreased serum levels of NO metabolites (nitrates) and decreased serum cGMP levels Controlled studies in infants with PPHN have shown that iNO is a safe and effective pulmonary vasodilator, improves oxygenation, has minimal systemic effects and decreases the need for ECMO
- Efficacy of inhaled nitric oxide in preterm infants ≤ 34 weeks: a . . .
Conclusion: Inhaled NO reduced the incidence of BPD in neonates at 36 weeks of gestation, and the effect of the treatment depended on neonatal age, birth weight, duration and dose of iNO Therefore, iNO can be considered a promising treatment for the potential prevention of BPD in premature infants
|
|